Literature DB >> 32935616

Erectile Dysfunction in a Sample of Sexually Active Young Adult Men from a U.S. Cohort: Demographic, Metabolic and Mental Health Correlates.

Jerel P Calzo1,2,3, S Bryn Austin3,4,5,6, Brittany M Charlton3,4,6,7, Stacey A Missmer6,7,8, Martin Kathrins9, Audrey J Gaskins6,10,11, Jorge E Chavarro6,7,10.   

Abstract

PURPOSE: Little is understood about physiological and psychological correlates of erectile dysfunction among younger men. We examined prevalence and correlates of erectile dysfunction in a large U.S. sample of 18 to 31-year-old men.
MATERIALS AND METHODS: Erectile dysfunction prevalence and severity (defined using the International Index of Erectile Function-5 scale) were examined in cross-sectional survey data from 2,660 sexually active men, age 18 to 31 years, from the 2013 Growing Up Today Study. Erectile dysfunction medication and supplement use were self-reported. Multivariable models estimated associations of moderate-to-severe erectile dysfunction with demographic (age, marital status), metabolic (body mass index, waist circumference, history of diabetes, hypertension, hypercholesterolemia) and mental health (depression, anxiety, antidepressant use, tranquilizer use) variables.
RESULTS: Among sexually active men 11.3% reported mild erectile dysfunction and 2.9% reported moderate-to-severe erectile dysfunction. Married/partnered men had 65% lower odds of erectile dysfunction compared to single men. Adjusting for history of depression, antidepressant use was associated with more than 3 times the odds of moderate-to-severe erectile dysfunction. Anxiety was associated with greater odds of moderate-to-severe erectile dysfunction, as was tranquilizer use. Few men (2%) reported using erectile dysfunction medication or supplements. However, among them, 29.7% misused prescription erectile dysfunction medication. Limitations include reliance upon cross-sectional data and the sample's limited racial/ethnic and socioeconomic diversity.
CONCLUSIONS: Erectile dysfunction was common in a large sample of sexually active young adult men from a U.S. cohort and was associated with relationship status and mental health. Health providers should screen for erectile dysfunction in young men, and monitor use of prescription erectile dysfunction medications and supplements for sexual functioning.

Entities:  

Keywords:  anxiety; depression; erectile dysfunction; marital status; prescription drug misuse

Mesh:

Year:  2020        PMID: 32935616      PMCID: PMC7790854          DOI: 10.1097/JU.0000000000001367

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

Review 1.  Erectile dysfunction.

Authors:  T F Lue
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

Review 2.  The International Index of Erectile Function (IIEF): a state-of-the-science review.

Authors:  R C Rosen; J C Cappelleri; N Gendrano
Journal:  Int J Impot Res       Date:  2002-08       Impact factor: 2.896

3.  Adulterated sexual enhancement supplements: more than mojo.

Authors:  Pieter A Cohen; Bastiaan J Venhuis
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

4.  Recreational use of erectile dysfunction medications in undergraduate men in the United States: characteristics and associated risk factors.

Authors:  Christopher B Harte; Cindy M Meston
Journal:  Arch Sex Behav       Date:  2010-04-01

5.  One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice.

Authors:  Paolo Capogrosso; Michele Colicchia; Eugenio Ventimiglia; Giulia Castagna; Maria Chiara Clementi; Nazareno Suardi; Fabio Castiglione; Alberto Briganti; Francesco Cantiello; Rocco Damiano; Francesco Montorsi; Andrea Salonia
Journal:  J Sex Med       Date:  2013-05-07       Impact factor: 3.802

6.  The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males.

Authors:  Mildred E Francis; John W Kusek; Leroy M Nyberg; Paul W Eggers
Journal:  J Urol       Date:  2007-06-13       Impact factor: 7.450

7.  Impact of a first treatment with phosphodiesterase inhibitors on men and partners' quality of sexual life: results of a prospective study in primary care.

Authors:  Pierre Costa; Gilles Grandmottet; Hien Duc Mai; Stéphane Droupy
Journal:  J Sex Med       Date:  2013-05-16       Impact factor: 3.802

8.  Impact of erectile dysfunction and its subsequent treatment with sildenafil: qualitative study.

Authors:  John Tomlinson; David Wright
Journal:  BMJ       Date:  2004-03-29

9.  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.

Authors:  H A Feldman; I Goldstein; D G Hatzichristou; R J Krane; J B McKinlay
Journal:  J Urol       Date:  1994-01       Impact factor: 7.450

10.  Safety and quality assessment of 175 illegal sexual enhancement products seized in red-light districts in Singapore.

Authors:  Min-Yong Low; Yun Zeng; Lin Li; Xiao-Wei Ge; Ruth Lee; Bosco-Chen Bloodworth; Hwee-Ling Koh
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

View more
  2 in total

1.  Mental Health in Non-Oncologic Urology Patients.

Authors:  Danyon Anderson; Devesh Kumar; Divya Divya; Jose L Zepeda; Abrahim N Razzak; Jamal Hasoon; Omar Viswanath; Alan D Kaye; Ivan Urits
Journal:  Health Psychol Res       Date:  2022-09-23

Review 2.  The Efficacy of Acupuncture on Patients with Erectile Dysfunction: A Review.

Authors:  Hao Wang; Ming Zhao; Jiwei Zhang; Bin Yan; Shengjing Liu; Feng Zhao; Jun Guo; Fu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-09       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.